in

Several companies worldwide claim to possess the required expertise and infrastructure to offer cont

Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to continue relying on contract service providers for various aspects of antibody-based product development and manufacturing.

To order this 285+ page report, which features 100+ figures and 110+ tables, please visit this link 

The USD 17 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed across the following segments:

Type of Antibodies

Monoclonal Antibodies

Bispecific Antibodies

ADCs

Others

  • Company Size
  • Small
  • Mid-sized
  • Large / Very Large

Scale of Operation

  • Preclinical / Clinical
  • Commercial

Type of expression system used

  • Mammalian
  • Microbial

Key geographical regions

North America

Europe

Asia and RoW

The Antibody Contract Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:  

  • AGC Biologics
  • Aldevron
  • AMRI
  • Boehringer Ingelheim BioXcellence
  • Emergent BioSolutions
  • Eurofins CDMO
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Lonza
  • Nitto Avecia Pharma Services
  • Novasep
  • Pierre Fabre
  • Samsung BioLogics
  • Synthon
  • Thermo Fisher Scientific

Table of Contents

 

1. Preface

 

2. Executive Summary

 

3. Introduction

 

4. Market Landscape

 

5. Company Competitive Analysis

 

6. Company Profiles

 

7. Case Study: Comparison of Small and Large Molecules (Biologics) Drugs / Therapies 

 

8. Benchmark Analysis

 

9. Partnerships

 

10. Recent Expansions

 

11. Capacity Analysis

 

12. Demand Analysis

 

13. Market Sizing and Opportunity Analysis

 

14. SWOT Analysis

 

15. Future of The Antibody CMO Market

 

16. Interview Transcripts

 

17. Appendix 1: List of Antibody Custom Manufacturers

 

18. Appendix 2: Tabulated Data

 

19. Appendix 3: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

This post was created with our nice and easy submission form. Create your post!

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Loading…

0

What do you think?

Most BTC Circulating Is From Long-Term Investors: Glassnode

Most BTC Circulating Is From Long-Term Investors: Glassnode

The “Antibody Contract Manufacturing Market, 2020-2030” report features an extensive study of the cu